tiprankstipranks
Trending News
More News >
Xspray Pharma AB (DE:6XP)
:6XP
Germany Market

Xspray Pharma AB (6XP) Ratios

Compare
1 Followers

Xspray Pharma AB Ratios

DE:6XP's free cash flow for Q1 2025 was kr0.00. For the 2025 fiscal year, DE:6XP's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.58 5.46 4.58 9.41 16.70
Quick Ratio
4.29 4.36 4.29 9.21 16.70
Cash Ratio
4.17 4.17 4.17 9.07 16.43
Solvency Ratio
-4.11 -2.37 -4.11 -2.82 -2.24
Operating Cash Flow Ratio
-3.82 -5.09 -3.82 -1.72 -2.41
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 4.96 0.00
Net Current Asset Value
kr 189.17Mkr 145.97Mkr 102.82Mkr 250.91Mkr 308.30M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.05 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.05 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 0.05 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.05 1.10 1.05 1.05 1.04
Debt Service Coverage Ratio
-10.06K -251.55 -10.06K 8.45 -8.48K
Interest Coverage Ratio
-11.09K -269.24 -11.09K -24.49K -8.91K
Debt to Market Cap
0.00 0.00 0.00 >-0.01 0.00
Interest Debt Per Share
0.10 1.41 0.10 0.17 0.28
Net Debt to EBITDA
5.00 0.76 0.97 3.06 6.29
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
98.93%99.99%98.93%100.00%99.80%
EBT Per EBIT
98.95%98.87%98.95%98.72%98.04%
Return on Assets (ROA)
-11.44%-23.48%-22.25%-15.52%-8.64%
Return on Equity (ROE)
-12.27%-25.91%-23.43%-16.34%-8.98%
Return on Capital Employed (ROCE)
-12.09%-25.05%-23.91%-16.52%-9.13%
Return on Invested Capital (ROIC)
-12.37%-24.89%-23.59%-16.76%-9.08%
Return on Tangible Assets
-17.69%-54.70%-65.19%-29.60%-14.00%
Earnings Yield
-3.59%-17.79%-10.75%-7.77%-1.55%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.64 0.74 0.64 0.53 0.17
Inventory Turnover
1.11 0.21 1.11 1.43 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-902.51 1.24K -238.71 -438.91 -2.18K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 1.74K 327.47 255.09 0.00
Days of Payables Outstanding
902.51 495.14 566.19 693.99 2.18K
Operating Cycle
0.00 1.74K 327.47 255.09 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-5.18 -7.65 -5.18 -2.66 -2.75
Free Cash Flow Per Share
-11.22 -9.68 -11.22 -7.60 -8.35
CapEx Per Share
6.03 2.04 6.03 4.94 5.60
Free Cash Flow to Operating Cash Flow
2.16 1.27 2.16 2.86 3.03
Dividend Paid and CapEx Coverage Ratio
-0.86 -3.76 -0.86 -0.54 -0.49
Capital Expenditure Coverage Ratio
-0.86 -3.76 -0.86 -0.54 -0.49
Operating Cash Flow Coverage Ratio
-51.82 -5.52 -51.82 -15.96 -9.84
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-9.88%-25.48%-19.68%-11.86%-4.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-9.30 -5.62 -9.30 -12.87 -64.42
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
2.18 1.46 2.18 2.10 5.78
Price-to-Free Cash Flow (P/FCF) Ratio
-5.08 -3.92 -5.08 -8.43 -23.24
Price-to-Operating Cash Flow Ratio
-11.00 -4.97 -11.00 -24.11 -70.50
Price-to-Earnings Growth (PEG) Ratio
-0.40 -0.55 -0.40 -0.20 -96.31
Price-to-Fair Value
2.18 1.46 2.18 2.10 5.78
Enterprise Value Multiple
-8.96 -5.18 -8.96 -11.11 -59.79
Enterprise Value
1.07B 880.47M 1.09B 975.74M 3.05B
EV to EBITDA
-26.23 -5.18 -8.96 -11.11 -59.79
EV to Sales
0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-8.50 -3.42 -4.59 -6.61 -21.03
EV to Operating Cash Flow
-31.34 -4.33 -9.93 -18.91 -63.79
Tangible Book Value Per Share
8.02 9.66 8.02 15.22 20.21
Shareholders’ Equity Per Share
26.15 26.09 26.15 30.48 33.54
Tax and Other Ratios
Effective Tax Rate
0.01 <0.01 0.01 >-0.01 <0.01
Revenue Per Share
0.00 0.00 0.00 0.00 0.00
Net Income Per Share
-6.13 -6.76 -6.13 -4.98 -3.01
Tax Burden
1.00 1.00 0.99 1.00 1.00
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.74 1.13 0.83 0.53 0.89
Currency in SEK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis